CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
- PMID: 11477410
- DOI: 10.1038/90675
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Abstract
Chemokines are chemoattractant proteins that are divided into subfamilies based upon cysteine signature motifs termed C, CC, CXC and CX3C. Chemokines have roles in immunity and inflammation that affect cell trafficking and activation of T cells as well as cells of the innate immune system. We report here CX3C chemokine mimicry for the G glycoprotein of respiratory syncytial virus (RSV) and show binding to CX3CR1--the specific receptor for the CX3C chemokine fractalkine--and induction of leukocyte chemotaxis. We also show that CX3CR1 facilitates RSV infection of cells. Thus, G glycoprotein interaction with CX3CR1 probably plays a key role in the biology of RSV infection.
Similar articles
-
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.J Infect Dis. 2004 Dec 1;190(11):1936-40. doi: 10.1086/425516. Epub 2004 Oct 28. J Infect Dis. 2004. PMID: 15529257 Clinical Trial.
-
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.J Immunol. 2006 Feb 1;176(3):1600-8. doi: 10.4049/jimmunol.176.3.1600. J Immunol. 2006. PMID: 16424189
-
T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.Pediatr Infect Dis J. 2006 May;25(5):410-4. doi: 10.1097/01.inf.0000214998.16248.b7. Pediatr Infect Dis J. 2006. PMID: 16645504
-
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.
-
Fractalkine in vascular biology: from basic research to clinical disease.Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):34-40. doi: 10.1161/01.ATV.0000095360.62479.1F. Epub 2003 Sep 11. Arterioscler Thromb Vasc Biol. 2004. PMID: 12969992 Review.
Cited by
-
Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia.Front Immunol. 2023 Dec 19;14:1282016. doi: 10.3389/fimmu.2023.1282016. eCollection 2023. Front Immunol. 2023. PMID: 38169867 Free PMC article.
-
Defining the Assembleome of the Respiratory Syncytial Virus.Subcell Biochem. 2023;106:227-249. doi: 10.1007/978-3-031-40086-5_9. Subcell Biochem. 2023. PMID: 38159230 Review.
-
The implication of infection with respiratory syncytial virus in pediatric recurrent wheezing and asthma: knowledge expanded post-COVID-19 era.Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):403-416. doi: 10.1007/s10096-023-04744-0. Epub 2023 Dec 28. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38153660 Review.
-
Host Responses to Respiratory Syncytial Virus Infection.Viruses. 2023 Sep 26;15(10):1999. doi: 10.3390/v15101999. Viruses. 2023. PMID: 37896776 Free PMC article. Review.
-
Interferons-Implications in the Immune Response to Respiratory Viruses.Microorganisms. 2023 Aug 29;11(9):2179. doi: 10.3390/microorganisms11092179. Microorganisms. 2023. PMID: 37764023 Free PMC article. Review.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
